<Suppliers Price>

SI-2 hydrochloride

Names

[ CAS No. ]:
1992052-49-9

[ Name ]:
SI-2 hydrochloride

Biological Activity

[Description]:

SI-2 hydrochloride (EPH 116 hydrochloride) is a highly promising SRC-3 SMI: SRC-3 inhibitor (PPI), with IC50 values of 3-20 nM for breast cancer cell death. SI-2 hydrochloride (EPH 116 hydrochloride) has a much improved toxicity and pharmacokinetic profile, with acceptable oral availability[1].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> Others >> Others

[Target]

IC50:3-20 nM (breast cancer cell death)[1].


[In Vitro]

SI-2 selectively reduce the transcriptional activities and the protein concentrations of SRC-3 in cells through direct physical interactions with SRC-3[1]. SI-2 selectively induces breast cancer cell death with IC50 values in the low nanomolar range (3-20 nM), but not affect normal cell viability[1]. SI-2 (100 nM) decreases cell motility, invasion, and tumor metastasis in MDAMB-468 cells[1]. Cell Viability Assay[1]. Cell Line: MDA-MB-468 cells. Concentration: 100 nM. Incubation Time: 12 hours. Result: Significantly reduced the motility of cancer cells. Western Blot Analysis[1]. Cell Line: MDAMB-468 cells. Concentration: 0-200 nM. Incubation Time: 24 hours. Result: Significantly reduced SRC-3 protein levels. Did not decrease the SRC-3 mRNA level. Western Blot Analysis[1]. Cell Line: Cancer cells. Concentration: 0-200 nM. Incubation Time: 24 hours. Result: Caused PARP cleavage.

[In Vivo]

SI-2 causes minimal acute cardiotoxicity based on a hERG channel blocking assay and an unappreciable chronic toxicity to major organs based on histological analyses[1]. SI-2 is a drug-like molecule and meets all of the criteria of Lipinski’s rule[1]. Animal Model: MDA-MB-468 breast cancer mouse model[1]. Dosage: 2 mg/kg. Administration: Twice daily for 5 weeks (Vehicle, PBS). Result: Significantly inhibit tumor growth. SRC-3 levels in SI-2–treated tumor tissues were significantly lower than the PBS treated control group. Animal Model: CD1 mice[1]. Dosage: 20 mg/kg (Pharmacokinetic Analysis). Administration: Intraperitoneal administration once. Result: T1/2 = 1 h, Cmax of 3.0 μM, and the time to reach the maximum plasma concentration tmax of 0.25 h. SI-2 only degrades slightly (less than 5%) at pH 1.6 and 3.0 within 6 h, and is stable in buffers with pH ≥ 5.

[References]

[1]. Song X, et al. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A. 2016 May 3;113(18):4970-5.

Chemical & Physical Properties

[ Molecular Formula ]:
C15H16ClN5

[ Molecular Weight ]:
301.77


Related Compounds